Literature DB >> 33834693

Estrogen receptor 2 mediates intraspecific aggressive behaviors of the female Cricetulus barabensis in the estrous cycle.

Jin-Hui Xu1, Hui-Liang Xue1, Zhe Wang1, Chao Fan1, Ming Wu1, Lai-Xiang Xu1.   

Abstract

The social behavior mechanisms have not been thoroughly reported in the solitary female striped dwarf hamster (Cricetulus barabensis). In this study, the handling bag test and neutral arena measurements were used to detect the changes of aggression in the face of rivals of different genders of wild striped dwarf hamsters. We found that female hamsters had the highest aggressive performance in proestrus, followed by estrus, and the lowest in metestrus and the dioestrus, and the increased aggression during the proestrus or estrus period was low-intensity aggression such as intimidation, shock, boxing and counterattack, or even ritualized non-harmful behaviors to drive away opponents. When confronted with male individuals, aggression in females decreased significantly during estrus. The concentration of plasma estradiol was the highest in estrus and the lowest in metestrus and dioestrus. In contrast, estrogen receptor 2 relative expression in the hypothalamus is the lowest in proestrus and highest in metestrus and dioestrus. Besides, both estradiol levels in plasma and estrogen receptor 2 mRNA in the hypothalamus were associated with aggression. These results will broaden our understanding of the molecular mechanism of how breeding phenotype is an essential driver in changing the social behavior of female Cricetulus barabensis.
© 2021 The Authors. Published by IMR Press.

Entities:  

Keywords:  Behavioral endocrinology; Estrogen receptor 2; Estrous cycle; Hypothalamus; Rodent; Social behavior mechanisms

Year:  2021        PMID: 33834693     DOI: 10.31083/j.jin.2021.01.302

Source DB:  PubMed          Journal:  J Integr Neurosci        ISSN: 0219-6352            Impact factor:   2.117


  1 in total

Review 1.  Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms.

Authors:  Jing Chen; Bixin Shen; Zhengli Jiang
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.